VLADYSLAVA INMAN: Open Payments
NPI 1306459516 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,318 in 106 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $96 · 2025 $2,318
Food & beverage: $2,301Education: $17
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $433 |
| HARMONY BIOSCIENCES LLC | 9 | $288 |
| Regeneron Healthcare Solutions, Inc. | 7 | $213 |
| Insmed, Inc. | 14 | $191 |
| GlaxoSmithKline, LLC. | 12 | $186 |
| Pulmonx Corporation | 1 | $150 |
| Viatris Specialty LLC | 6 | $141 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $129 |
| GENZYME CORPORATION | 5 | $111 |
| Verona Pharma, Inc. | 4 | $77 |
Products named: DUPIXENT, WAKIX, TEZSPIRE, Arikayce, CHARTIS CATHETER, YUPELRI, OFEV, NUCALA.
Industry payments across TN — which companies pay providers there.
